Vascular Pharmaceuticals is Drug Discovery in United States that focus on drugs feature monoclonal antibody business. Founded in 2005. They cover business area such as developer, diabetic therapeutic drug, complication, diabetes, type, patient, diabetic nephropathy.
2005
( 19 years old in 2024 )
Drugs Feature Monoclonal Antibody
-
79 TW Alexander Drive, Research Commons, Building 4401
Suite 200A, Research Triangle Park
Durham, NC 27709
United States
Private
developerdiabetic therapeutic drugcomplicationdiabetestypepatientdiabetic nephropathy
* We use standard office opening hours in near Vascular Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vascular Pharmaceuticals is Drug Discovery business from United States that founded in 2005 (19 years old in 2024), Vascular Pharmaceuticals business is focusing on Drugs Feature Monoclonal Antibody.
Vascular Pharmaceuticals headquarter office and corporate office address is located in 79 TW Alexander Drive, Research Commons, Building 4401 Suite 200A, Research Triangle Park Durham, NC 27709 United States.
Vascular Pharmaceuticals was founded in United States.
In 2024, Vascular Pharmaceuticals is currently focus on drugs feature monoclonal antibody sector.
Above is snippet of Google Trends for "drugs feature monoclonal antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vascular Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
